Analysen zu SAFRAN S.A.
| 28.04.25 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 25.04.25 | SAFRAN Overweight | Barclays Capital | |
| 25.04.25 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | SAFRAN Outperform | RBC Capital Markets | |
| 15.04.25 | SAFRAN Buy | Deutsche Bank AG | |
| 14.04.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 07.04.25 | SAFRAN Overweight | Barclays Capital | |
| 04.04.25 | SAFRAN Outperform | RBC Capital Markets | |
| 21.03.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 24.02.25 | SAFRAN Kaufen | DZ BANK | |
| 17.02.25 | SAFRAN Buy | Deutsche Bank AG | |
| 17.02.25 | SAFRAN Outperform | RBC Capital Markets | |
| 14.02.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 14.02.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 14.02.25 | SAFRAN Outperform | RBC Capital Markets | |
| 14.02.25 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 10.02.25 | SAFRAN Outperform | RBC Capital Markets | |
| 24.01.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 14.01.25 | SAFRAN Outperform | RBC Capital Markets | |
| 13.01.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 17.12.24 | SAFRAN Buy | Deutsche Bank AG | |
| 12.12.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 06.12.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 06.12.24 | SAFRAN Outperform | RBC Capital Markets | |
| 05.12.24 | SAFRAN Outperform | RBC Capital Markets | |
| 05.12.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | SAFRAN Outperform | RBC Capital Markets | |
| 26.11.24 | SAFRAN Overweight | Barclays Capital | |
| 05.11.24 | SAFRAN Overweight | Barclays Capital | |
| 04.11.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 25.10.24 | SAFRAN Kaufen | DZ BANK | |
| 25.10.24 | SAFRAN Outperform | RBC Capital Markets | |
| 14.10.24 | SAFRAN Outperform | RBC Capital Markets | |
| 18.09.24 | SAFRAN Kaufen | DZ BANK | |
| 11.09.24 | SAFRAN Outperform | RBC Capital Markets | |
| 22.08.24 | SAFRAN Kaufen | DZ BANK | |
| 31.07.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 20.06.24 | SAFRAN Overweight | Barclays Capital | |
| 07.05.24 | SAFRAN Overweight | Barclays Capital | |
| 29.04.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.03.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.02.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | SAFRAN Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 13.01.26 | Symrise Buy | Deutsche Bank AG | |
| 13.01.26 | TKMS thyssenkrupp Marine Systems Buy | Deutsche Bank AG | |
| 13.01.26 | ArcelorMittal Buy | Deutsche Bank AG | |
| 13.01.26 | AUMOVIO Buy | UBS AG | |
| 13.01.26 | Symrise Buy | UBS AG | |
| 13.01.26 | ING Group Buy | UBS AG | |
| 13.01.26 | Air Liquide Buy | UBS AG | |
| 13.01.26 | Continental Buy | UBS AG | |
| 13.01.26 | Michelin Neutral | UBS AG | |
| 13.01.26 | Mercedes-Benz Group Neutral | UBS AG | |
| 13.01.26 | Porsche vz. Neutral | UBS AG | |
| 13.01.26 | Stellantis Buy | UBS AG | |
| 13.01.26 | Volvo Car AB Registered b Sell | UBS AG | |
| 13.01.26 | Volkswagen Neutral | UBS AG | |
| 13.01.26 | Schaeffler Neutral | UBS AG | |
| 13.01.26 | Valeo Neutral | UBS AG | |
| 13.01.26 | BMW Neutral | UBS AG | |
| 13.01.26 | Renault Sell | UBS AG | |
| 13.01.26 | arGEN-X Neutral | UBS AG | |
| 13.01.26 | Continental Market-Perform | Bernstein Research | |
| 13.01.26 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 13.01.26 | Gerresheimer Underperform | Bernstein Research | |
| 13.01.26 | T-Mobile US Overweight | Barclays Capital | |
| 13.01.26 | Redcare Pharmacy Buy | Jefferies & Company Inc. | |
| 13.01.26 | Sixt Buy | Jefferies & Company Inc. | |
| 13.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | Münchener Rückversicherungs-Gesellschaft Hold | Jefferies & Company Inc. | |
| 13.01.26 | Philips Market-Perform | Bernstein Research | |
| 13.01.26 | Siemens Healthineers Outperform | Bernstein Research | |
| 13.01.26 | Nokia Buy | Jefferies & Company Inc. | |
| 13.01.26 | arGEN-X Buy | Jefferies & Company Inc. | |
| 13.01.26 | JOST Werke Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.01.26 | adesso Hold | Jefferies & Company Inc. | |
| 13.01.26 | Sartorius Stedim Biotech Outperform | Bernstein Research | |
| 13.01.26 | Sartorius vz. Outperform | Bernstein Research | |
| 13.01.26 | Michelin Outperform | Bernstein Research | |
| 13.01.26 | Scout24 Overweight | Barclays Capital | |
| 13.01.26 | Kontron Buy | Jefferies & Company Inc. | |
| 13.01.26 | Michelin Underweight | Barclays Capital | |
| 13.01.26 | Nordea Bank Abp Registered Shs Underweight | Barclays Capital | |
| 13.01.26 | Orsted Hold | Jefferies & Company Inc. | |
| 13.01.26 | JENOPTIK Buy | Jefferies & Company Inc. | |
| 13.01.26 | Richemont Buy | Jefferies & Company Inc. | |
| 13.01.26 | FUCHS Buy | Jefferies & Company Inc. | |
| 13.01.26 | TUI Market-Perform | Bernstein Research | |
| 13.01.26 | Michelin Buy | Jefferies & Company Inc. | |
| 13.01.26 | CTS Eventim Buy | Jefferies & Company Inc. | |
| 13.01.26 | Boeing Buy | Jefferies & Company Inc. | |
| 13.01.26 | Nordex Buy | Jefferies & Company Inc. | |
| 13.01.26 | Scout24 Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.